Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced the initiation of recruitment and the dosing of its first patient in a clinical trial assessing safety and efficacy of its lead asset in multiple solid tumor indications…
